209 related articles for article (PubMed ID: 21632541)
1. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
4. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system.
Blum FC; Chen C; Kroken AR; Barbieri JT
Infect Immun; 2012 May; 80(5):1662-9. PubMed ID: 22392932
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
Peng L; Tepp WH; Johnson EA; Dong M
PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
[TBL] [Abstract][Full Text] [Related]
7. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
Rummel A
Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
[TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
9. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
[TBL] [Abstract][Full Text] [Related]
10. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
Karalewitz AP; Kroken AR; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
Biochemistry; 2010 Sep; 49(37):8117-26. PubMed ID: 20731382
[TBL] [Abstract][Full Text] [Related]
11. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
Kroken AR; Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
FEBS J; 2011 Dec; 278(23):4486-96. PubMed ID: 21554541
[TBL] [Abstract][Full Text] [Related]
12. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P; Dong M; Dupuy J; Chapman ER; Stevens RC
J Mol Biol; 2010 Apr; 397(5):1287-97. PubMed ID: 20219474
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D.
Zhang Y; Buchko GW; Qin L; Robinson H; Varnum SM
Biochem Biophys Res Commun; 2010 Oct; 401(4):498-503. PubMed ID: 20858456
[TBL] [Abstract][Full Text] [Related]
15. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites.
Strotmeier J; Gu S; Jutzi S; Mahrhold S; Zhou J; Pich A; Eichner T; Bigalke H; Rummel A; Jin R; Binz T
Mol Microbiol; 2011 Jul; 81(1):143-56. PubMed ID: 21542861
[TBL] [Abstract][Full Text] [Related]
16. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
17. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER
J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
